Find Faculty
Igor Bado, PhD
img_Igor Bado
ASSISTANT PROFESSOR | Oncological Sciences
email
Research Topics
Breast Cancer, Cancer, Epigenetics, Metastasis
Multi-Disciplinary Training Area
Cancer Biology [CAB]
New topic
Dr. Bado studies how different tumor microenvironments crosstalk with cancer cells to promote survival, growth, and secondary spread to other organs. His goal is to understand epigenetic implications in cancer cell adaptation, intra-tumoral heterogeneity, and multi-organ metastasis. He believes that epigenetic factors -which modulate gene expression, are key players in the metastatic process and can be targeted to reprogram cancer cells toward improved therapeutic responses. Ultimately, he aims to identify therapeutic vulnerabilities for the long-term remission of metastatic diseases. He uses state-of-the-art approaches to dissect the mechanisms driving breast cancer metastasis from the early dissemination of CTCs to the formation of macro-metastases in advanced stages of the disease.

BSc, University of Ouagadougou

PhD, University of Houston

Postdoctoral, Baylor College of Medicine

2022

Biomedical Laureate

Icahn School of Medicine at Mount Sinai

2022

Dean’s Award of Excellence

Baylor College of Medicine

2022

NCI Pathway to Independence Award (K99/R00)

National Cancer Institute

2021

SPORE-Breast Center Career Enhancement Program Awardee

Baylor College of Medicine

22
Publications

Selected Publications

Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal. Xiaoxin Hao, Yichao Shen, Nan Chen, Weijie Zhang, Elizabeth Valverde, Ling Wu, Hilda L. Chan, Zhan Xu, Liqun Yu, Yang Gao, Igor Bado, Laura Natalee Michie, Charlotte Helena Rivas, Luis Becerra Dominguez, Sergio Aguirre, Bradley C. Pingel, Yi Hsuan Wu, Fengshuo Liu, Yunfeng Ding, David G. Edwards, Jun Liu, Angela Alexander, Naoto T. Ueno, Po Ren Hsueh, Chih Yen Tu, Liang Chih Liu, Shu Hsia Chen, Mien Chie Hung, Bora Lim, Xiang H.F. Zhang. Cell Stem Cell

Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2<sup>+</sup> Cells. Weijie Zhang, Zhan Xu, Xiaoxin Hao, Tiancheng He, Jiasong Li, Yichao Shen, Kai Liu, Yang Gao, Jun Liu, David G. Edwards, Aaron M. Muscarella, Ling Wu, Liqun Yu, Longyong Xu, Xi Chen, Yi Hsuan Wu, Igor L. Bado, Yunfeng Ding, Sergio Aguirre, Hai Wang, Zbigniew Gugala, Robert L. Satcher, Stephen T.C. Wong, Xiang H.F. Zhang. Cancer Discovery

Improving the odds together: a framework for breast cancer research scientists to include patient advocates in their research. Hillary Stires, Igor Bado, Thelma Brown, Martha Carlson, Isaac S. Chan, Gloria V. Echeverria, Andrew J. Ewald, Bora Lim, Carla Lloyd, Julia Maues, Steffi Oesterreich, Robert N. Riter, Kelly Shanahan, Alana L. Welm, Josh Newby. npj Breast Cancer

View All Publications

Hess CSM Building Floor 5 Room 108

1470 Madison Ave

New York, NY 10029

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Bado during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.